http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103159784-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-04 |
| filingDate | 2013-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103159784-B |
| titleOfInvention | A kind of cefuroxime lysine and preparation thereof |
| abstract | The present invention relates to a cefuroxime lysine compound, cefuroxime lysine containing 98 ~ 99.99wt% in cefuroxime lysine described in it, the deammoniation methanoyl cephalofruxin of 0.01 ~ 2%, the molecular formula of deammoniation methanoyl cephalofruxin is such as formula shown in I: the stability of the cefuroxime lysine that the present invention obtains is very strong, higher than prior art, foreign matter content and polymer content all lower than the cefuroxime lysine of prior art, are highly suitable for clinical application. |
| priorityDate | 2013-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 82.